Richard Gaynor

Insider Reports History

Entity
Individual
Location
C/O Neon Therapeutics, 40 Erie Street, Suite 110, Cambridge, MA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Gaynor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 46.6K $908K $19.50 Sep 3, 2024 Direct
Alkermes plc. Director Ordinary Shares 25K $602K $24.10 Jun 29, 2024 Direct
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 May 31, 2024 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45K Jun 16, 2022 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 Jun 29, 2024 Direct

Insider Reports Filed by Richard Gaynor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZLAB Zai Lab Ltd Sep 3, 2024 1 -$48.8K 4 Sep 5, 2024 Director
ALKS Alkermes plc. Jun 29, 2024 3 -$35.3K 4 Jul 1, 2024 Director
ZLAB Zai Lab Ltd Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
ALKS Alkermes plc. May 31, 2024 10 $61.4K 4 Jun 4, 2024 Director
ALKS Alkermes plc. Jul 7, 2023 3 -$42.7K 4 Jul 10, 2023 Director
ALKS Alkermes plc. Jun 29, 2023 2 $0 4 Jun 30, 2023 Director
ZLAB Zai Lab Ltd Jun 29, 2023 1 $500K 4 Jun 30, 2023 Director
ALKS Alkermes plc. Jul 7, 2022 2 $0 4 Jul 8, 2022 Director
INFI INFINITY PHARMACEUTICALS, INC. Jun 16, 2022 1 $0 4 Jun 16, 2022 Director
ALKS Alkermes plc. Jun 14, 2022 3 -$18.9K 4 Jun 16, 2022 Director
ALKS Alkermes plc. Dec 2, 2021 3 -$29.6K 4 Dec 3, 2021 Director
ZLAB Zai Lab Ltd Nov 19, 2021 1 $0 4 Nov 22, 2021 Director
ZLAB Zai Lab Ltd Nov 19, 2021 0 $0 3 Nov 22, 2021 Director
ALKS Alkermes plc. Jun 14, 2021 2 $0 4 Jun 16, 2021 Director
INFI INFINITY PHARMACEUTICALS, INC. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
ALKS Alkermes plc. May 20, 2021 3 -$30.8K 4 May 21, 2021 Director